D. A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. J. Borowitz et al., The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-405, 2016.

E. B. Heikamp and C. H. Pui, Next-generation evaluation and treatment of pediatric acute lymphoblastic leukemia, J Pediatr, vol.203, pp.14-24, 2018.

L. W. Ding, Q. Y. Sun, K. T. Tan, W. Chien, A. Mayakonda et al., Mutational landscape of pediatric acute lymphoblastic leukemia, Cancer Res, vol.77, issue.2, pp.390-400, 2017.

M. Qian, X. Cao, M. Devidas, W. Yang, C. Cheng et al., TP53 Germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children, J Clin Oncol, vol.36, issue.6, pp.591-600, 2018.

K. H. Vousden and C. Prives, Blinded by the light: the growing complexity of p53, Cell, vol.137, issue.3, pp.413-444, 2009.

M. L. Tornesello, C. Annunziata, A. L. Tornesello, L. Buonaguro, and F. M. Buonaguro, Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers, Cancers (Basel), vol.10, issue.7, p.213, 2018.

M. P. Markey, Regulation of MDM4, Front Biosci, vol.16, pp.1144-56, 2011.

K. Onel and C. Cordon-cardo, Mol Cancer Res, vol.2, issue.1, pp.1-8, 2004.

A. Gembarska, F. Luciani, C. Fedele, E. A. Russell, M. Dewaele et al., MDM4 is a key therapeutic target in cutaneous melanoma, Nat Med, vol.18, issue.8, pp.1239-1286, 2012.

J. Liu, C. Zhang, Y. Zhao, and Z. Feng, MicroRNA control of p53, J Cell Biochem, vol.118, issue.1, pp.7-14, 2017.

L. Shaham, V. Binder, N. Gefen, A. Borkhardt, and S. Izraeli, MiR-125 in normal and malignant hematopoiesis, Leukemia, vol.26, issue.9, pp.2011-2019, 2012.

V. Marcel, M. L. Dichtel-danjoy, C. Sagne, H. Hafsi, D. Ma et al., Biological functions of p53 isoforms through evolution: lessons from animal and cellular models, Cell Death Differ, vol.18, issue.12, pp.1815-1839, 2011.
URL : https://hal.archives-ouvertes.fr/ensl-00814713

J. C. Bourdon, p53 and its isoforms in cancer, Br J Cancer, vol.97, issue.3, pp.277-82, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00409543

J. C. Bourdon, K. Fernandes, F. Murray-zmijewski, G. Liu, A. Diot et al., p53 isoforms can regulate p53 transcriptional activity, Genes Dev, vol.19, issue.18, pp.2122-2159, 2005.

A. M. Mondal, I. Horikawa, S. R. Pine, K. Fujita, K. M. Morgan et al., p53 isoforms regulate aging-and tumor-associated replicative senescence in T lymphocytes, J Clin Invest, vol.123, issue.12, pp.5247-57, 2013.

W. M. Chan, W. Y. Siu, A. Lau, and R. Y. Poon, How many mutant p53 molecules are needed to inactivate a tetramer?, Mol Cell Biol, vol.24, issue.8, pp.3536-51, 2004.

H. Kim, K. Kim, J. Choi, K. Heo, H. J. Baek et al., p53 requires an intact C-terminal domain for DNA binding and transactivation, J Mol Biol, vol.415, issue.5, pp.843-54, 2012.

C. G. Mullighan, S. Goorha, I. Radtke, C. B. Miller, E. Coustan-smith et al., Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia, Nature, vol.446, issue.7137, pp.758-64, 2007.

I. R. Watson, K. Takahashi, P. A. Futreal, and L. Chin, Emerging patterns of somatic mutations in cancer, Nat Rev Genet, vol.14, issue.10, pp.703-721, 2013.

H. Hafsi, D. Santos-silva, S. Courtois-cox, and P. Hainaut, Effects of Delta40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53, BMC Cancer, vol.13, p.134, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01261793

S. Courtois, G. Verhaegh, S. North, M. G. Luciani, P. Lassus et al., DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53, Oncogene, vol.21, issue.44, pp.6722-6730, 2002.

K. Fujita, A. M. Mondal, I. Horikawa, G. H. Nguyen, K. Kumamoto et al., p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence, Nat Cell Biol, vol.11, issue.9, pp.1135-1177, 2009.

N. Von-muhlinen, I. Horikawa, F. Alam, K. Isogaya, D. Lissa et al., p53 isoforms regulate premature aging in human cells, Oncogene, vol.37, issue.18, pp.2379-93, 2018.

I. Horikawa, K. Y. Park, K. Isogaya, Y. Hiyoshi, H. Li et al., Delta133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells, Cell Death Differ, vol.24, issue.6, pp.1017-1045, 2017.

M. Milanovic, D. Fan, D. Belenki, J. Dabritz, Z. Zhao et al., Senescence-associated reprogramming promotes cancer stemness, Nature, vol.553, issue.7686, pp.96-100, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02364397

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations